Strategic thinking for bottom-line results
Enjoy complimentary access to the latest strategies, ideas and enabling technology driving business today. Our experts and leading thought-leaders discuss how the latest technologies are leveraged to meet business challenges and drive bottom-line impact.
This webcast will provide in house counsel, compliance professionals, and HR with an overview of:
mergermarket, in association with IntraLinks, hosted the live webcast, Intellectual Property M&A. The webcast will discuss some the importance of Intellectual Property as a driver of M&A.
In this latest quarterly podcast, mergermarket and IntraLinks assembled a panel of transatlantic dealmakers to discuss what influenced M&A from April to September. After a bumper first half for global deal volumes, Q3 saw the market hit by a wave of uncertainty over sovereign debt and sluggish global economic growth. But what was our panel’s impression of the market?
Discover how IntraLinks can help Fund Administrators capitalize on emerging opportunities while controlling their costs. The presentation will walk you through the IntraLinks solutions and capabilities Fund Administrators are leveraging to expand their service suite, engage earlier with prospects and attract large self administered funds that are moving to 3rd party administration.
Understand how the use of extended enterprise collaboration technologies is helping the clinical research community gain operational efficiencies and strengthen relationships between clinical research sites and Sponsors/CROs. Hear firsthand how clinical research sites interact, correspond, collaborate and share information with Sponsor Organizations, and their perceived challenges with their current methods.
"Taking the process online with IntraLinks solves many logistics problems, and will ultimately result in better returns for our shareholders and an expedited process overall."
Barbara Jeremiah - Executive Vice President, Corporate Development
Cancer drug developer immatics biotechnologies prides itself on open communication. Using IntraLinks to manage due diligence, immatics showed investors they could trust the company. What resulted was the largest private biotech financing round in Germany since 2001. In the process, immatics saved time and resources, and gave investors an efficient way to review information.
In my capacity as VP of Life Sciences Product Marketing at IntraLinks, I attended the second annual "Patient Recruitment in Clinical Trials" seminar hosted by the Cambridge Healthtech Institute in May, and in a presentation by Brian York, Director, Feasibility and Patient Recruitment at Amgen, he shared that 87% of physicians are not involved in clinical trials. The top reason cited for this (38%) was "lack of opportunity."